Multidrug resistance-associated protein 4 in pharmacology: Overview of its contribution to pharmacokinetics, pharmacodynamics and pharmacogenetics.

Life Sci

INSERM, UMR 1248, F-87000 Limoges, France; CHU Limoges, Service de pharmacologie, toxicologie et pharmacovigilance, F-87000 Limoges, France. Electronic address:

Published: August 2019

MRP4 is an ABC membrane transporter involved in clinical outcomes as it is located in many tissues that manages the transport and the elimination of many drugs. This review explores the implication of MRP4 in clinical pharmacology and the importance of its genetic variability. Although there is no specific recommendation regarding the study of MRP4 in drug development, it should be considered when drugs are eliminated by the kidney or liver or when drug-drug interactions are expected.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lfs.2019.06.015DOI Listing

Publication Analysis

Top Keywords

multidrug resistance-associated
4
resistance-associated protein
4
protein pharmacology
4
pharmacology overview
4
overview contribution
4
contribution pharmacokinetics
4
pharmacokinetics pharmacodynamics
4
pharmacodynamics pharmacogenetics
4
pharmacogenetics mrp4
4
mrp4 abc
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!